
Deals & Capital Markets
AbbVie Nears $20B+ Deal for Revolution Medicines, Capping Historic RAS Rally
3d ago
You're signed outSign in or to get full access.
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
View earnings summary and analysis
Research analysts covering AbbVie.